Deciphering progesterone's mechanisms of action in breast cancer
A new research perspective was published in Oncotarget, titled "Deciphering the mechanisms of action of progesterone in breast cancer."
Jul 10, 2023
0
0
A new research perspective was published in Oncotarget, titled "Deciphering the mechanisms of action of progesterone in breast cancer."
Jul 10, 2023
0
0
A new editorial paper titled "ERβ as a mediator of estrogen signaling in inflammatory breast cancer" has been published in Oncotarget.
Jul 3, 2023
0
1
A study led by researchers at Sanford Burnham Prebys has found that in young women, certain genetic mutations are associated with treatment-resistant breast cancer. These mutations are not linked to treatment-resistant breast ...
Jun 30, 2023
0
52
A new study by investigators from Mass General Brigham has found that artificial intelligence (AI) language models like ChatGPT can accurately identify appropriate imaging services for two important clinical presentations: ...
Jun 22, 2023
0
48
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer ...
Jun 13, 2023
0
21
In situ bioprinting, which involves 3D printing biocompatible structures and tissues directly within the body, has seen steady progress over the past few years. In a recent study, a team of researchers developed a handheld ...
Jun 13, 2023
0
255
A research team at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine compiled and analyzed statistics from federal cancer research funding sources and found that funds tend to be allocated ...
Jun 8, 2023
0
5
A new research paper titled "Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression" has been published in Oncotarget.
Jun 5, 2023
0
9
The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, ...
May 23, 2023
0
2
A team led by researchers at Baylor College of Medicine is coming closer to delivering on the promise of personalized breast cancer therapy with a strategy to predict the most likely response of a cancer to a specific less ...
May 17, 2023
0
22